Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders, Inherited

Explore clinical trials studying Blood Coagulation Disorders, Inherited. Study availability and eligibility vary by location and protocol.

861 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders, Inherited trial results

Completed

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

NCT00885742

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Study Site Dothan, Alabama, United States
  • Study Site Oakland, California, United States
  • Study Site Orange, California, United States
  • Study Site San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

NCT01233440

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Study site Vienna, Austria
  • Study site Le Kremlin-Bicêtre, France
  • Study Site Lyon, France
  • Study site Nantes, France
View all 20 locations
View Trial Details
Completed

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

NCT00883090

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Study Site Dothan, Alabama, United States
  • Study Site Orange, California, United States
  • Study Site San Francisco, California, United States
  • Study Site Stockton, California, United States
View Trial Details
Completed

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

NCT00364182

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site New Brunswick, New Jersey, United States
View all 19 locations
View Trial Details
Completed

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • La Jolla, California, United States
  • Detroit, Michigan, United States
  • Detroit, Michigan, United States
  • Chapel Hill, North Carolina, United States
View all 17 locations
View Trial Details

Related conditions